₹2686.45▲1.86%
1.73%
Low
Day's Volatility:2.20%
High
0.47%
40.50%
Low
52 Weeks Volatility:42.64%
High
2.14%
Returns % | |
1 Month Return | 2.6 % |
3 Month Return | 5.2 % |
1 Year Return | 62.66 % |
Market Stats | |
Previous Close | ₹2,637.40 |
Open | ₹2,639.90 |
Volume | 2.55L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹89,257.59Cr |
based on 29 analysts
Based on 29 analysts offering long term price targets for Torrent Pharmaceuticals Ltd. An average target of ₹2728.41
Source: S&P Global Market Intelligence
Organisation | Torrent Pharmaceuticals Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd gained for a third straight session, rising 2.01% to Rs 2690.45 on the NSE. The stock has risen around 4.67% in the last month and has a PE of 76.53 based on TTM earnings ending December 23.
Torrent Pharmaceuticals Positioned for Strong Earnings Growth - 16 Apr, 2024
Torrent Pharmaceuticals has a P/E ratio of 57.1x, higher than half of all companies in India. Analysts predict earnings to grow by 25% annually over the next three years, positioning the company for strong future growth.
Torrent Pharma Receives Tax Demand Order Worth Rs 3.99 Crore - 09 Apr, 2024
Torrent Pharmaceuticals received a tax demand order worth Rs 3.99 crore for the current fiscal year under Section 73 of the Goods and Service Act, 2017. The company stated that it would file an appeal and expressed optimism regarding a favourable outcome at the appellate level.
Torrent Pharmaceuticals Reports Increase in Revenue and Net Profits - 06 Apr, 2024
Torrent Pharmaceuticals, a significant player in the Indian pharmaceutical industry, reported an increase in revenue by 2.7% from Rs. 2,660 crores to Rs. 2,732 crores during the September quarter to December quarter. Additionally, net profits increased by around 15% from Rs. 386 crores to Rs. 443 crores during the same period. The company is set to restart production of Penicillin G by mid-2024.
Torrent Pharma in Talks to Buy KKR's Stake in JB Chemicals - 01 Apr, 2024
Torrent Pharmaceuticals is reportedly in early discussions with KKR to buy its majority stake in JB Chemicals & Pharmaceuticals. The potential deal is still at a preliminary stage, and other buyout funds have also shown interest. KKR acquired a 54% stake in JB Pharma from its promoters for approximately Rs 3,100 crore in July 2020. The
Torrent Pharmaceuticals ROE Study Shows Positive Impact on Earnings Growth Potential - 29 Mar, 2024
A study of Torrent Pharmaceuticals' return on equity (ROE) shows a positive impact on the company's earnings growth potential. With a 13% increase in stock price over the past three months, investors may be influenced by the company's long-term fundamentals.
Torrent Pharmaceuticals Ltd Gains for Fifth Straight Session - 27 Mar, 2024
Torrent Pharmaceuticals Ltd stock is up 0.14% on the day, quoting at Rs 2574 as of 12:44 IST on NSE. The benchmark NIFTY is up around 0.7%, while Sensex is up 0.75%. The PE ratio of the stock is 74.59 based on TTM earnings ending December 23.
Fundamentals of Torrent Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 4 quarters, 287.0 Cr → 443.0 Cr (in ₹), with an average increase of 13.0% per quarter
FII Holding Up
Foreign Institutions have increased holdings from 14.09% to 14.14% in Mar 2024 quarter
Revenue Rich
Revenue is up for the last 6 quarters, 2.30K Cr → 2.78K Cr (in ₹), with an average increase of 3.7% per quarter
Price Rise
In the last 7 days, TORNTPHARM stock has moved up by 3.6%
Best in 1 Year
In the last 1 year, TORNTPHARM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Promoter Holding Unchanged
Promoters holdings remained unchanged at 71.25% of holdings in Mar 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 133.9% return, outperforming this stock by 23.9%
MF Holding Down
Mutual Funds have decreased holdings from 4.48% to 4.46% in Mar 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 7.45% to 7.36% in Mar 2024 quarter
Torrent Pharmaceuticals Ltd in the last 5 years
Lowest (31.60x)
April 2, 2018
Today (59.74x)
April 23, 2024
Industry (61.41x)
April 23, 2024
Highest (73.85x)
April 3, 2019
Funds | Holdings |
Kotak Emerging Equity Scheme Direct Growth | 1.51% |
UTI Flexi Cap Fund - Growth Option - Direct | 1.23% |
Nippon India Pharma Fund - Direct Plan - Growth Plan | 2.2% |
Kotak Small Cap Direct Growth | 0.87% |
Axis Growth Opportunities Fund Direct Growth | 0.89% |
Investors | Holdings % | Prev. 1 periods | 3M change |
---|---|---|---|
Promoter Holdings | 71.25% | 0.00 | |
Foreign Institutions | 14.14% | 0.00 | |
Mutual Funds | 4.46% | 0.00 | |
Retail Investors | 7.36% | 0.00 | |
Others | 2.8% | 0.00 |
Technicals of Torrent Pharmaceuticals Ltd share
News & Events of Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd (TORNTPHARM) share price today is ₹2686.45
Torrent Pharmaceuticals Ltd is listed on NSE
Torrent Pharmaceuticals Ltd is listed on BSE
PE Ratio of Torrent Pharmaceuticals Ltd is 59.74
PE ratio = Torrent Pharmaceuticals Ltd Market price per share / Torrent Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Torrent Pharmaceuticals Ltd(TORNTPHARM) is 2.55L.
Today’s market capitalisation of Torrent Pharmaceuticals Ltd(TORNTPHARM) is ₹89257.59Cr.
Torrent Pharmaceuticals Ltd(TORNTPHARM | Price |
---|---|
52 Week High | ₹2744 |
52 Week Low | ₹1598.45 |
Torrent Pharmaceuticals Ltd(TORNTPHARM) share price is ₹2686.45. It is down -2.10% from its 52 Week High price of ₹2744
Torrent Pharmaceuticals Ltd(TORNTPHARM) share price is ₹2686.45. It is up 68.07% from its 52 Week Low price of ₹1598.45
Torrent Pharmaceuticals Ltd(TORNTPHARM | Returns |
---|---|
1 Day Returns | 49.05% |
1 Month Returns | 2.6% |
3 Month Returns | 5.2% |
1 Year Returns | 62.66% |